Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA)
India flag India · Delayed Price · Currency is INR
1,700.00
+13.80 (0.82%)
May 13, 2025, 3:29 PM IST

NSE:SUNPHARMA Cash Flow Statement

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Mar '24 Mar '23 Mar '22 Mar '21 Mar '20 2015 - 2019
Net Income
95,76484,73632,72729,03837,649
Upgrade
Depreciation & Amortization
24,90624,77121,09020,29620,085
Upgrade
Other Amortization
661.7533.4435.8503.9443
Upgrade
Loss (Gain) From Sale of Assets
1,662227.11,65616.753.7
Upgrade
Asset Writedown & Restructuring Costs
-1.5-10-88.7--
Upgrade
Loss (Gain) From Sale of Investments
-921.96.23,126-2,596-819
Upgrade
Provision & Write-off of Bad Debts
905.92,071175.743.11,068
Upgrade
Other Operating Activities
-12,248-6,12215,133-11,239-1,918
Upgrade
Change in Accounts Receivable
3,529-9,532-13,423937.3-3,741
Upgrade
Change in Inventory
5,988-12,0223,070-10,8032,568
Upgrade
Change in Accounts Payable
2,49711,8243,6993,815-2,101
Upgrade
Change in Other Net Operating Assets
-1,393-46,88822,24431,69212,259
Upgrade
Operating Cash Flow
121,35049,59389,84561,70465,548
Upgrade
Operating Cash Flow Growth
144.69%-44.80%45.61%-5.86%198.43%
Upgrade
Capital Expenditures
-22,018-20,856-14,950-11,701-15,420
Upgrade
Sale of Property, Plant & Equipment
308.4210.1606.1971920.3
Upgrade
Cash Acquisitions
-1,433-46,858-7,396-616-
Upgrade
Divestitures
--238.4--
Upgrade
Investment in Securities
9,325-16,436-37,91113,733-17,019
Upgrade
Other Investing Activities
7,1234,5032,1012,0943,946
Upgrade
Investing Cash Flow
-6,902-79,437-57,2475,362-25,888
Upgrade
Short-Term Debt Issued
1,430-1,064-2,189
Upgrade
Long-Term Debt Issued
45,72781,59816,56866,029105,516
Upgrade
Total Debt Issued
47,15781,59817,63266,029107,705
Upgrade
Short-Term Debt Repaid
--1,305--1,726-
Upgrade
Long-Term Debt Repaid
-82,287-30,010-45,286-109,199-138,935
Upgrade
Total Debt Repaid
-82,287-31,315-45,286-110,925-138,935
Upgrade
Net Debt Issued (Repaid)
-35,13050,283-27,654-44,896-31,230
Upgrade
Repurchase of Common Stock
----559.5-2,125
Upgrade
Common Dividends Paid
-28,982-25,189-21,589-15,595-13,792
Upgrade
Other Financing Activities
-2,990-1,333-2,6921,246-10,005
Upgrade
Financing Cash Flow
-67,10223,761-51,935-59,805-57,151
Upgrade
Foreign Exchange Rate Adjustments
-739.91,5711,274-1,2973,635
Upgrade
Miscellaneous Cash Flow Adjustments
12.95,667414.5--
Upgrade
Net Cash Flow
46,6191,155-17,6485,964-13,857
Upgrade
Free Cash Flow
99,33228,73874,89550,00250,128
Upgrade
Free Cash Flow Growth
245.65%-61.63%49.78%-0.25%-
Upgrade
Free Cash Flow Margin
20.48%6.55%19.38%14.93%15.27%
Upgrade
Free Cash Flow Per Share
41.4011.9831.2120.8420.89
Upgrade
Cash Interest Paid
2,1901,325732.11,4432,719
Upgrade
Cash Income Tax Paid
15,69415,098-9,69210,02916,294
Upgrade
Levered Free Cash Flow
75,8287,91175,69384,28936,587
Upgrade
Unlevered Free Cash Flow
77,3188,98676,48985,17338,479
Upgrade
Change in Net Working Capital
-8,01753,623-18,938-35,902-2,447
Upgrade
Updated Jan 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.